Last reviewed · How we verify

NCT06615518

Comparison of Clinical Effectiveness of Full Endoscopic Lumbar Discectomy (FELD) and Microdiscectomy (MD) in Patients With Lumbar Disc Herniation

Active, enrolled NA Last updated 20 November 2025
What this trial tests

NA trial testing transforaminal endoscopic lumbar discectomy in Lumbar Degenerative Disease in 220 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
1 March 2024
Primary endpoint
12 January 2025
1 December 2025

Quick facts

Lead sponsorUniversity of Opole
PhaseNA
StatusActive, enrolled
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment220
Start date1 March 2024
Primary completion12 January 2025
Estimated completion1 December 2025
Sites2 locations across Poland

Drugs / interventions tested

Conditions studied

Sponsor

University of Opole

Who can join

Adults 18 to 85, any sex, with Lumbar Degenerative Disease or Lumbar Radiculopathy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this clinical trial is to compare the clinical effectiveness of Full Endoscopic Lumbar Discectomy (FELD) and Microdiscectomy (MD) in patients aged 18-85 with single-level lumbar disc herniation who have not undergone prior lumbar surgery. This study also aims to perform a radiological analysis of MRI scans before and after treatment to optimize patient selection and surgical strategies. The main questions it aims to answer are: * Does FELD provide superior early postoperative pain relief (measured by VAS) compared to MD? * Does FELD offer better functional recovery (measured by COMI and ODI scores) postoperatively compared to MD? * Can radiological analysis of pre- and post-operative MRI images help optimize patient qualification and guide surgical strategies? Researchers will compare patients undergoing FELD to those undergoing MD to see if endoscopic techniques result in faster recovery and lower early postoperative pain while maintaining similar long-term outcomes. The study will also analyze how MRI findings correlate with clinical outcomes to refine operative decision-making. Participants will: * Undergo either FELD or MD surgery * Complete VAS, COMI, and ODI questionnaires at pre-specified follow-up intervals (1, 3, 6, and 12 months post-surgery) * Have MRI scans 24 hours before surgery, 24 hours after surgery, and at each follow-up to assess disc recurrence, residual pathology, and to optimize surgical strategies.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Tissue engineering strategies for treating intervertebral disc degeneration.
    Nie G, Liu W, Zeng F, Hu J, et al · · 2025 · cited 2× · PMID 40727644 · DOI 10.3389/fbioe.2025.1582189

Verify or expand the search:

Other recruiting trials for Lumbar Degenerative Disease

Currently open trials in the same condition.

Other University of Opole trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06615518.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing